Suppr超能文献

肾移植受者中,手术耐受与慢性排斥反应时对比的血液及移植物内Toll样受体4 mRNA谱。

Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients.

作者信息

Braudeau Cécile, Ashton-Chess Joanna, Giral Magali, Dugast Emilie, Louis Stephanie, Pallier Annaick, Braud Christophe, Moreau Anne, Renaudin Karine, Soulillou Jean-Paul, Brouard Sophie

机构信息

INSERM, U643, France.

出版信息

Transplantation. 2008 Jul 15;86(1):130-6. doi: 10.1097/TP.0b013e31817b8dc5.

Abstract

BACKGROUND

Deciphering the mechanisms of tolerance and chronic rejection (CR) remains a major goal in transplantation. Data in rodents suggest that Toll-like receptors (TLR), regulators of innate immune responses, play a role in determining graft outcome. However, few studies have focused on TLR expression in human kidney transplant recipients.

METHODS

Here, we analyzed the expression of TLR4 in peripheral blood mononuclear cells from kidney recipients with contrasted clinical situations: operational tolerance and CR, compared with patients with stable graft function, nontransplant patients with renal failure and healthy volunteers.

RESULTS

We report that myeloid differentiation factor 88 and TLR4 are significantly contrasted in the peripheral blood mononuclear cells, and in particular in monocytes, of patients with CR versus operational tolerance. Chronic rejection patients have significantly increased TLR4 and myeloid differentiation factor 88 compared with operationally tolerant patients, who resemble healthy volunteers and nontransplant patients with renal failure. Interestingly, analysis of TLR4 transcripts in graft biopsies from patients with normal histology or CR reflected the blood findings, with a significant increase of TLR4 in CR.

CONCLUSIONS

These data support a link between TLR4 expression and long-term graft outcome. Moreover, whereas absence of TLR signaling may be a feature of tolerance, increased TLR4 signaling may be implicated in CR.

摘要

背景

解析耐受和慢性排斥反应(CR)的机制仍是移植领域的一个主要目标。啮齿动物实验数据表明,作为天然免疫反应调节因子的Toll样受体(TLR)在决定移植物转归中发挥作用。然而,很少有研究关注人类肾移植受者体内TLR的表达情况。

方法

在此,我们分析了处于不同临床状况的肾移植受者外周血单个核细胞中TLR4的表达情况,这些状况包括手术耐受和CR,并与移植肾功能稳定的患者、肾衰竭非移植患者及健康志愿者进行比较。

结果

我们发现,CR患者与手术耐受患者相比,其外周血单个核细胞,尤其是单核细胞中的髓样分化因子88和TLR4存在显著差异。与类似健康志愿者及肾衰竭非移植患者的手术耐受患者相比,慢性排斥反应患者的TLR4和髓样分化因子88显著增加。有趣的是,对组织学正常或发生CR的患者移植肾活检标本中TLR4转录本的分析反映了血液检测结果,CR患者的TLR4显著增加。

结论

这些数据支持TLR4表达与移植物长期转归之间存在关联。此外,虽然缺乏TLR信号可能是耐受的一个特征,但TLR4信号增强可能与CR有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验